{"id":"26f9efdb-b44b-5386-9861-7d5651bde785","stable_key":"dc8975b1-95ff-5d9b-be17-a1c04610cca7:mo-xdh-xanthine","predicate":"oxidizes","statement":"Recombinant human XDH/XOR catalyzed conversion of xanthine to urate.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"606b0521-c475-57c0-bd11-8a43cac4675e","mechanism_event_label":"The purine-breakdown pathway uses a molybdenum enzyme to make urate.","subject":{"id":"8de34d8a-46dc-512c-a82f-d169747b496e","slug":"xdh","display_name":"Human xanthine oxidoreductase / XDH","entity_type_key":"protein"},"object":{"id":"0a8b817b-52c5-5b98-b1d8-d6677651744c","slug":"xanthine","display_name":"Xanthine","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"606b0521-c475-57c0-bd11-8a43cac4675e","stable_key":"dc8975b1-95ff-5d9b-be17-a1c04610cca7:mo-xdh-xanthine-event","event_type":"biochemical_relationship","label":"The purine-breakdown pathway uses a molybdenum enzyme to make urate.","description":"Recombinant human XDH/XOR catalyzed conversion of xanthine to urate.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"8b3659b4-1c0e-57f1-ae60-c9300b21359d","slug":"urate","display_name":"Urate / uric acid","entity_type_key":"small_molecule"},"role":"product","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"2af426f5-f843-58be-be7c-73e90053bddb","slug":"sulfurated-moco","display_name":"Terminal-sulfido molybdenum cofactor for XDH and AOX1","entity_type_key":"small_molecule"},"role":"cofactor","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"e2cd7179-f218-54e8-9ce9-7a836ae35fac","slug":"fad","display_name":"FAD","entity_type_key":"small_molecule"},"role":"cofactor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"02107865-f169-5624-9ea4-9448a4cce185","slug":"iron-sulfur-2fe2s","display_name":"[2Fe-2S] iron-sulfur cluster","entity_type_key":"chemical_species"},"role":"cofactor","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"8de34d8a-46dc-512c-a82f-d169747b496e","slug":"xdh","display_name":"Human xanthine oxidoreductase / XDH","entity_type_key":"protein"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"0a8b817b-52c5-5b98-b1d8-d6677651744c","slug":"xanthine","display_name":"Xanthine","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/molybdenum-research/37713777.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"30e93ea24784120403bef1dfe72cf46411f1af88946b9cc1cba3d4c45a367bf9\", \"start_char\": 0, \"end_char\": 1655, \"text_sha256\": \"30e93ea24784120403bef1dfe72cf46411f1af88946b9cc1cba3d4c45a367bf9\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Recombinant human XDH variants with urate, superoxide and NO assays","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Xanthine, oxygen and inorganic nitrite assays","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The 2023 Fig. 6E corrigendum corrects a displayed panel; authors state data and conclusions are unchanged. Enzyme activity is not a clinical benefit or dietary response.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Molybdenum research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"molybdenum","display_name":"Molybdenum","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Homo sapiens protein","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The purine-breakdown pathway uses a molybdenum enzyme to make urate.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[mo-p37713777] Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health? (2023). https://pubmed.ncbi.nlm.nih.gov/37713777/ DOI: 10.1016/j.redox.2023.102864","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Purified human enzyme","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"9925f093-30f1-54ec-a25b-29a420fd3eb7","evidence_kind":"source_excerpt","locator":"Lines 742-753","start_line":742,"end_line":753,"excerpt":"### mo-xdh-xanthine\nRecombinant human XDH/XOR catalyzed conversion of xanthine to urate.\nCondition category: normal\nnutrient_topic: Molybdenum research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: The purine-breakdown pathway uses a molybdenum enzyme to make urate.\norganism: Homo sapiens protein\ntissue_or_cell_type: Purified human enzyme\nexperimental_model: Recombinant human XDH variants with urate, superoxide and NO assays\nlimitations: The 2023 Fig. 6E corrigendum corrects a displayed panel; authors state data and conclusions are unchanged. Enzyme activity is not a clinical benefit or dietary response.\nexposure: Xanthine, oxygen and inorganic nitrite assays\nevidence_span: {\"source_cache\": \"artifacts/molybdenum-research/37713777.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"30e93ea24784120403bef1dfe72cf46411f1af88946b9cc1cba3d4c45a367bf9\", \"start_char\": 0, \"end_char\": 1655, \"text_sha256\": \"30e93ea24784120403bef1dfe72cf46411f1af88946b9cc1cba3d4c45a367bf9\"}\n[mo-p37713777] Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health? (2023). https://pubmed.ncbi.nlm.nih.gov/37713777/ DOI: 10.1016/j.redox.2023.102864","model_system":"Recombinant human XDH variants with urate, superoxide and NO assays","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [mo-p37713777] Natural mutations of human XDH promote the nitrite (NO2-)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health? (2023). https://pubmed.ncbi.nlm.nih.gov/37713777/ DOI: 10.1016/j.redox.2023.102864","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"1aa6da60-8284-5252-8dd9-ac2250d5ced5","stable_key":"import-dc8975b1-95ff-5d9b-be17-a1c04610cca7","title":"Molybdenum: cofactor assembly, sulfur metabolism and nutrient interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"143147eb9ac7fe750bdd33bb50d7773bc0cd49cc94faf219aebce3c3d760dd8f","revision_id":"90c2239d-290b-5e16-815a-f94d30569ebd","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}